A Study of the Efficacy and Safety of RoActemra/Actemra in Patients With Rheumatoid Arthritis.
Status:
Completed
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
This open-label, single-arm study will evaluate the safety and efficacy of RoActemra/Actemra
alone or concomitant with other antirheumatic drugs when administered as a single, weekly
injection in patients with rheumatoid arthritis.